Became Member: 31st January 2013
Left House: 31st August 2017 (Retired)
Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
These initiatives were driven by Lord Bishop of Truro, and are more likely to reflect personal policy preferences.
Lord Bishop of Truro has not introduced any legislation before Parliament
Lord Bishop of Truro has not co-sponsored any Bills in the current parliamentary sitting
There is no data available to answer questions 1, 2, 3 & 5. Please see table below in response to question 4;
October 2014 – September 2015 | |
| STBA Applications Received 228,039 | 228,039 |
| STBA Primary Benefit Paid | 52,517 |
| % Primary Benefit Paid against Applications Received | 23.0% |
For context we have also provided STBA Applications Received.
The data provided is for Employment and Support Allowance, Incapacity Benefits, Jobseeker’s Allowance and Income Support. The Secretary of State announced on 8 December 2014 that DWP would do more to raise the awareness of Short Term Benefit Advances and as well as more information now on Gov.UK there should be posters and leaflets in all Jobcentres.
The data is only available from October 14 therefore we have provided the latest 12 months’ worth of data.
Only Working Age Benefits (i.e. ESA, IB, JSA and IS) are included in the above information for benefit advance applications as the number of applications received for State Pension Credit and Carer’s Allowance is not available.
The Source for the date is as follows: STBA Applications Received & Primary Benefits Paid - Management Information System Programme (MISP). This collation is based on clerical counts submitted by the Centres and is Internal MI which has been agreed for use in publications of Parliamentary questions and Freedom of Information requests.
The information you have requested is not currently available. The Department published its strategy for releasing official statistics on Universal Credit (UC) in September 2013. As outlined in the strategy, officials are currently quality assuring data for UC therefore it is not yet possible to give a definitive list of what statistics will be provided in the future. These statistics however will be published in accordance with the relevant protocols in the Code of Practice for official statistics.
Clinicians are responsible for prescribing home oxygen and robust oxygen assessment services are in place across the country.
In terms of personalisation, there is little specific evidence to suggest that prescribing of oxygen for idiopathic pulmonary fibrosis should be any different from that of chronic obstructive pulmonary disease or other causes of respiratory failure. Oxygen therapy is the treatment for the lack of oxygen whatever the specific disease.
Commissioning of home oxygen services should be overseen by clinical commissioning groups except where an individual requires specialised services. In these circumstances, oxygen therapy is covered in the service specification for specialised commissioning of interstitial lung disease. Where oxygen is prescribed at home, NHS England would expect that training is given by the provider on the correct use of the equipment.
NHS England expects commissioners and providers to take account of National Institute for Health and Care Excellence (NICE) guidance on oxygen and rehabilitation in commissioning and providing these services. A NICE Quality Standard is also being developed in this area.
In addition, the British Thoracic Society (which is NICE accredited) is due to launch its home oxygen clinical guidelines in February 2015.
Clinicians are responsible for prescribing home oxygen and robust oxygen assessment services are in place across the country.
In terms of personalisation, there is little specific evidence to suggest that prescribing of oxygen for idiopathic pulmonary fibrosis should be any different from that of chronic obstructive pulmonary disease or other causes of respiratory failure. Oxygen therapy is the treatment for the lack of oxygen whatever the specific disease.
Commissioning of home oxygen services should be overseen by clinical commissioning groups except where an individual requires specialised services. In these circumstances, oxygen therapy is covered in the service specification for specialised commissioning of interstitial lung disease. Where oxygen is prescribed at home, NHS England would expect that training is given by the provider on the correct use of the equipment.
NHS England expects commissioners and providers to take account of National Institute for Health and Care Excellence (NICE) guidance on oxygen and rehabilitation in commissioning and providing these services. A NICE Quality Standard is also being developed in this area.
In addition, the British Thoracic Society (which is NICE accredited) is due to launch its home oxygen clinical guidelines in February 2015.
Clinicians are responsible for prescribing home oxygen and robust oxygen assessment services are in place across the country.
In terms of personalisation, there is little specific evidence to suggest that prescribing of oxygen for idiopathic pulmonary fibrosis should be any different from that of chronic obstructive pulmonary disease or other causes of respiratory failure. Oxygen therapy is the treatment for the lack of oxygen whatever the specific disease.
Commissioning of home oxygen services should be overseen by clinical commissioning groups except where an individual requires specialised services. In these circumstances, oxygen therapy is covered in the service specification for specialised commissioning of interstitial lung disease. Where oxygen is prescribed at home, NHS England would expect that training is given by the provider on the correct use of the equipment.
NHS England expects commissioners and providers to take account of National Institute for Health and Care Excellence (NICE) guidance on oxygen and rehabilitation in commissioning and providing these services. A NICE Quality Standard is also being developed in this area.
In addition, the British Thoracic Society (which is NICE accredited) is due to launch its home oxygen clinical guidelines in February 2015.